Waldencast plc - Class A Ordinary Share (NQ:WALD)

1.720 -0.080 (-4.44%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 23, 2026 Add to My Watchlist

Price and Volume

Volume	68,007
Open	1.770
Bid (Size)	1.720 (500)
Ask (Size)	1.730 (300)
Prev. Close	1.800
Today's Range	1.710 - 1.800
52wk Range	1.450 - 3.540
Shares Outstanding	9,342,874
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

February 17, 2026

Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic...

From Waldencast plc

Via GlobeNewswire

Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

February 06, 2026

DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices

From Waldencast plc

Via GlobeNewswire

Performance

YTD	+0.6%	+0.6%
1 Month	-1.1%	-1.1%
3 Month	-40.3%	-40.3%
6 Month	-2.3%	-2.3%
1 Year	-43.8%	-43.8%

More News

Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

February 05, 2026

From Waldencast plc

Via GlobeNewswire

Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect

February 03, 2026

From Waldencast plc

Via GlobeNewswire

Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

January 30, 2026

From Waldencast plc

Via GlobeNewswire

Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

January 28, 2026

From Waldencast plc

Via GlobeNewswire

UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

January 27, 2026

From Waldencast plc

Via GlobeNewswire

Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™

January 27, 2026

From Waldencast plc

Via GlobeNewswire

CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

January 26, 2026

From Waldencast plc

Via GlobeNewswire

Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

January 26, 2026

From Waldencast plc

Via GlobeNewswire

Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler

January 21, 2026

From Waldencast plc

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

November 24, 2025

From Waldencast plc

Via GlobeNewswire

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

November 16, 2025

From Waldencast plc

Via GlobeNewswire

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

November 14, 2025

From Waldencast plc

Via GlobeNewswire

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

November 12, 2025

From Waldencast plc

Via GlobeNewswire

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

October 08, 2025

From Waldencast plc

Via GlobeNewswire

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

September 10, 2025

From Waldencast plc

Via GlobeNewswire

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2025

Via Benzinga

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

August 18, 2025

From Waldencast plc

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

August 18, 2025

Via Chartmill

Earnings Scheduled For August 18, 2025 ↗

August 18, 2025

Via Benzinga

Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

August 18, 2025

Via Benzinga

Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast

July 23, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Waldencast plc - Class A Ordinary Share publicly traded?

Yes, Waldencast plc - Class A Ordinary Share is publicly traded.

What exchange does Waldencast plc - Class A Ordinary Share trade on?

Waldencast plc - Class A Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Waldencast plc - Class A Ordinary Share?

The ticker symbol for Waldencast plc - Class A Ordinary Share is WALD on the Nasdaq Stock Market

What is the current price of Waldencast plc - Class A Ordinary Share?

The current price of Waldencast plc - Class A Ordinary Share is 1.720

When was Waldencast plc - Class A Ordinary Share last traded?

The last trade of Waldencast plc - Class A Ordinary Share was at 02/23/26 04:00 PM ET

What is the market capitalization of Waldencast plc - Class A Ordinary Share?

The market capitalization of Waldencast plc - Class A Ordinary Share is 16.07M

How many shares of Waldencast plc - Class A Ordinary Share are outstanding?

Waldencast plc - Class A Ordinary Share has 16M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.